Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI and Effects on Infarct Size and Microvascular Obstruction

NCT00299377 is registered in ClinicalTrials.gov with University of Leipzig as lead sponsor.

NCT NCT00299377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00299377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of Abciximab i.v. Versus i.c. in Primary PCI Patients With STEMI and Effects on Infarct Size and Microvascular Obstruction
Lead sponsor
University of Leipzig
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2006
Completion date
February 29, 2008
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction